TopFunds

Cooper Companies (The)

NASDAQ: COO

Stock price

59.66 USD

(+0%) TODAY

Health Care SuppliesMedical - Instruments & Supplies
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
4.1
5.6
7.5
2.8
9.3
4.8
14.8
1.9
1.5
2
1.9
(7.6)%
02Free cash flow per share
0.8
1.8
2.4
2.4
2.1
0.9
2.6
2.3
1.1
1.4
2.2
11.2%
03Dividends per share
-
-
-
-
-
-
-
-
-
-
-
-
04Dividends payout, %
1.4%
1.1%
0.8%
2.1%
0.6%
1.3%
0.1%
0.8%
1%
-
-
-
PROFIT AND LOSS STATEMENT
05Revenue
$ 1,797
$ 1,967
$ 2,139
$ 2,533
$ 2,653
$ 2,431
$ 2,923
$ 3,308
$ 3,593
$ 3,895
$ 4,092
8.6%
06% Change
-
9.5%
8.8%
18.4%
4.8%
(8.4)%
20.2%
13.2%
8.6%
8.4%
5.1%
8.6%
07Cost of revenue
(726.8)
(793.7)
(773.2)
(900.5)
(896.6)
(896.1)
(966.7)
(1,169)
(1,235)
(1,300)
(1,610)
8.3%
08Gross profit
1,070
1,173
1,366
1,632
1,757
1,535
1,956
2,140
2,358
2,596
2,483
8.8%
09% Margin
59.6%
59.6%
63.9%
64.5%
66.2%
63.1%
66.9%
64.7%
65.6%
66.6%
60.7%
63.8% A
10Operating expenses
(833.6)
(849)
(936.7)
(1,205)
(1,229)
(1,223)
(1,450)
(1,632)
(1,825)
(1,890)
(1,800)
8%
11% of Revenue
(46.4)%
(43.2)%
(43.8)%
(47.6)%
(46.3)%
(50.3)%
(49.6)%
(49.3)%
(50.8)%
(48.5)%
(44)%
(47.3)% A
12Operating Income
236.7
324.1
429.1
403.1
546.7
311.8
505.8
507.6
533.1
705.7
682.9
11.2%
13Income tax expense
(10.3)
(20.7)
(21.1)
(192)
(10.7)
(28.1)
(2,453)
(89.5)
(118.7)
(190)
(191.6)
33.9%
14Net Income
203.5
273.9
372.9
139.9
466.7
238.4
2,945
385.8
294.2
392.3
374.9
6.3%
15% Margin
11.3%
13.9%
17.4%
5.5%
17.6%
9.8%
100.8%
11.7%
8.2%
10.1%
9.2%
19.6% A
16Shares Outstanding
196,800
196,000
198,400
198,800
200,200
198,200
199,400
198,800
199,200
200,400
200,000
0.2%
17EPS Basic
4.2
5.7
7.6
2.9
9.5
4.9
14.9
2
1.5
2
1.9
(7.7)%
18EPS Diluted
4.1
5.6
7.5
2.8
9.3
4.8
14.8
1.9
1.5
2
1.9
(7.6)%
19EBITDA
425
520.1
615.8
689.7
826.2
622.9
823.9
878.7
885.9
1,072
1,053
9.5%
% Margin
23.7%
26.4%
28.8%
27.2%
31.1%
25.6%
28.2%
26.6%
24.7%
27.5%
25.7%
26.9% A
20Net Interest Income (expense)
(18.1)
(26.2)
(33.4)
(82.7)
(68)
(36.8)
(23.1)
(57.3)
(105.3)
(114.3)
(100)
18.6%
21Net Debt / EBITDA
3.1
2.4
1.8
2.8
2.1
3.1
1.7
3
2.8
2.3
2.5
2.5 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
16.4
100.8
88.8
77.7
89
115.9
95.9
138.2
120.8
107.6
110.6
21%
23Short-term investments
-
-
-
-
-
-
-
-
-
-
-
-
24Accounts receivable
282.9
291.4
316.6
374.7
435.3
435.4
515.3
557.8
609.7
717
829
11.4%
25Other current assets
122.4
127.2
93.7
169.7
132.2
152.5
268.5
208.9
238.8
324.2
320.8
10.1%
26Inventory
419.7
417.7
454.1
468.8
506.9
570.4
585.6
628.7
735.6
802.7
846
7.3%
27Total Current Assets
841.8
934.5
953.2
1,091
1,163
1,274
1,465
1,534
1,705
1,952
2,106
9.6%
Non-Current Assets
28Net property, plant & equipment
967.1
877.7
910.1
976
1,132
1,542
1,348
1,433
1,633
1,863
2,082
8%
29Long-term investments
-
-
-
-
-
-
-
-
-
-
-
-
30Other non-current assets
2,652
2,664
2,995
4,046
3,979
3,921
6,793
8,526
8,321
8,500
8,206
12%
31Total Non-Current Assets
3,619
3,542
3,906
5,022
5,111
5,463
8,141
9,959
9,954
10,364
10,288
11%
Total Assets
4,461
4,476
4,859
6,113
6,275
6,738
9,606
11,492
11,659
12,315
12,395
10.8%
LIABILITIES
Current Liabilities
32Accounts payable
116.9
107.4
142.1
146.4
150.1
176
161.4
248.8
261.9
260.5
300.4
9.9%
33Short-term debt
243.8
226.3
23.4
37.1
563.7
442.6
83.4
412.6
45.4
33.3
86.3
(9.9)%
34Other current liabilities
204.7
202.8
230.6
353
396.8
385.8
487.3
618.8
661.7
729
726.1
13.5%
35Total Current Liabilities
565.4
536.5
396.1
536.5
1,111
1,004
732.1
1,280
969
1,023
1,113
7%
Non-Current Liabilities
36Long-term debt
1,105
1,107
1,149
1,986
1,263
1,621
1,398
2,351
2,524
2,550
2,698
9.3%
37Other non-current liabilities
111.8
132.1
137.5
282.8
272.7
287.6
534.5
686.6
615.1
658.4
344.9
11.9%
38Total Non-Current Liabilities
1,217
1,240
1,287
2,269
1,535
1,908
1,932
3,037
3,139
3,209
3,043
9.6%
39Total Liabilities
1,787
1,776
1,683
2,805
2,646
2,913
2,664
4,318
4,108
4,232
4,156
8.8%
SHAREHOLDERS` EQUITY
40Common stock
5.2
5.2
5.2
5.3
5.3
5.3
5.4
5.4
21.6
21.7
21.8
15.5%
41Retained earnings / (deficit)
1,779
2,050
2,434
2,576
3,026
3,262
6,202
6,585
6,876
7,268
7,643
15.7%
42Accumulated other comprehensive income / (loss)
(191.6)
(489.6)
(375.3)
(430.7)
(447.1)
(472)
(341.3)
(466.8)
(453.8)
(421.7)
(406.5)
7.8%
43Noncontrolling interests
6.4
0.2
0.1
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
(29.3)%
44Total shareholders' equity
2,674
2,696
3,176
3,308
3,629
3,825
6,942
7,175
7,551
8,084
8,239
11.9%
45Total Liabilities and shareholders' Equity
4,461
4,476
4,859
6,113
6,275
6,738
9,606
11,492
11,659
12,315
12,395
10.8%
46Total Debt
1,349
1,334
1,173
2,023
1,826
2,063
1,481
2,763
2,569
2,584
2,784
7.5%
47Net Debt
1,333
1,233
1,084
1,945
1,737
1,947
1,385
2,625
2,448
2,476
2,673
7.2%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
203.5
273.9
372.9
139.9
466.7
238.4
2,945
385.8
294.2
392.3
374.9
6.3%
49Depreciation & amortization
191.4
198.3
188.4
275.1
280.8
319.6
309.3
346.1
367.7
375.1
423
8.3%
50Share-based compensation expense
-
-
37.2
43.2
35.1
-
-
-
-
-
-
-
51Changes in working capital and other assets
(4)
37.4
(4.9)
210.7
(69.4)
(71.4)
(2,515)
(39.5)
(54.4)
(58.1)
(1.8)
(7.6)%
52Net cash flows from operating activities
391
509.6
593.6
668.9
713.2
486.6
738.6
692.4
607.5
709.3
796.1
7.4%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(243)
(152.6)
(127.2)
(193.6)
(292.1)
(310.4)
(214.4)
(242)
(392.5)
(421.2)
(362.4)
4.1%
54Purchases of investments / marketable securities
-
-
-
-
-
-
-
-
-
-
-
-
55Proceeds from maturities of marketable securities
-
-
-
-
-
-
-
-
-
-
-
-
56Other investing activities
(44.9)
(266.1)
(254.1)
(1,324)
(59.2)
(54.1)
(235.9)
(1,589)
(56.5)
(343.4)
(10.5)
(13.5)%
57Net cash flows from investing activities
(287.9)
(418.7)
(381.3)
(1,518)
(351.3)
(364.5)
(450.3)
(1,831)
(449)
(764.6)
(372.9)
2.6%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(72.1)
-
(55)
-
(148.3)
(31.6)
1.5
(62.4)
23
63.9
(274.1)
14.3%
59Dividends paid, net
(2.9)
(2.9)
(2.9)
(2.9)
(3)
(3)
(3)
(3)
(3)
-
-
-
60Debt issuance (repayments), net
(37.2)
(27.6)
(162.5)
845.7
(200.1)
(42.7)
(309.9)
1,279
(180.8)
5.6
(79.9)
7.9%
61Other financing activities
5.6
29.1
(7.5)
1.6
-
(18.2)
-
(19.7)
(13.1)
(30.3)
(71.9)
-
62Net cash flows from financing activities
(106.7)
(1.4)
(227.9)
844.4
(351.4)
(95.5)
(311.4)
1,194
(173.9)
39.2
(425.9)
14.9%
63Increase (decrease) in cash and cash equivalents
(8.8)
84.4
(12)
(11.1)
11.8
27.3
(20.5)
42.3
(17.7)
(13.2)
2.9
-
64Cash and equivalents, ending balance
16.4
100.8
88.8
77.7
89.5
116.8
96.3
138.6
120.9
107.7
110.6
21%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
147.9
357
466.4
475.3
421.1
176.2
524.2
450.4
215
288.1
433.7
11.4%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

Cooper Companies (The) (COO) financial statements and performance

Explore Cooper Companies (The) (COO) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.